<MedlineCitation Status="Completed">
<MedlineID>10011516</MedlineID>
<PMID>369622</PMID>
<DateCreated>
<Year>1979</Year>
<Month>05</Month>
<Day>26</Day>
</DateCreated>
<DateCompleted>
<Year>1979</Year>
<Month>05</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised>
<Year>2001</Year>
<Month>11</Month>
<Day>19</Day>
</DateRevised>
<Article>
<Journal>
<ISSN>0320-9725</ISSN>
<JournalIssue>
<Volume>44</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1979</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
</Journal>
<ArticleTitle>[Substrate specificity of peptidases catalyzing LH-RH degradation in hypothalamus, liver and heart of rat]</ArticleTitle>
<Pagination>
<MedlinePgn>86-92</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Degradation of [125I]-LH-RH by peptidases of hypothalamus, liver and heart of the rat and the effects of LH-RH, LH-RH antagonist D-Phe2-Phe3-D-Phe6-LH-RH, LH-RH5-10, oxytocin, bradikinin, thyrotrophin-releasing hormone, melanocyte-inhibiting factor, luteinizing, follicle-stimulating, lactogenic and growth hormones were studied. It was shown that the degradation was inhibited with maximal efficiency by non-labelled LH-RH (Ki = 1,7--2,0 . 10(-6) M). This observation is indicative of peptidase specificity for LH-RH. It is assumed that specific peptidases of liver and heart are involved in the reglation of LH-RH concentration in these organs.</AbstractText>
</Abstract>
<AuthorList>
<Author>
<LastName>Bakalkin</LastName>
<ForeName>G Ia</ForeName>
<Initials>GIa</Initials>
</Author>
<Author>
<LastName>Tsibezov</LastName>
<ForeName>V V</ForeName>
<Initials>VV</Initials>
</Author>
<Author>
<LastName>Isachenkov</LastName>
<ForeName>V A</ForeName>
<Initials>VA</Initials>
</Author>
</AuthorList>
<Language>rus</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Izuchenie cubstratnoÄ­ spetsifichnosti peptidaz gipotalamusa, pecheni i serdtsa krys, rasshchepliaiushchikh liuliberin.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>USSR</Country>
<MedlineTA>Biokhimiia</MedlineTA>
<NlmUniqueID>0372667</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Hormones</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>33515-09-2</RegistryNumber>
<NameOfSubstance>Gonadorelin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4</RegistryNumber>
<NameOfSubstance>Peptide Hydrolases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName>Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Comparative Study</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>English Abstract</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Gonadorelin</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Hormones</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Hypothalamus</DescriptorName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Liver</DescriptorName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Myocardium</DescriptorName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Peptide Hydrolases</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Substrate Specificity</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
